Premium
Platelet gel in wound treatment in patient with pemphigus vulgaris and Type 2 diabetes mellitus: Case report
Author(s) -
Šijan Goran,
Vojvodić Aleksandra,
Milićević Saša,
Vučetić Dušan,
Petrov Nenad,
Kozarski Jefta,
Đorđević Boban,
Ostojić Nikola,
Nikolić Živan,
Mitrić Biljana,
Malivuković Ana,
Stepić Nenad
Publication year - 2019
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.13099
Subject(s) - medicine , wound healing , hemostasis , platelet , pemphigus vulgaris , diabetes mellitus , surgery , platelet rich plasma , amputation , wound closure , dermatology , endocrinology
Treatment of wounds, especially in patients with systemic diseases, is very difficult and time consuming, and it represents great challenge. Complications like infections and impaired healing are regularly seen in these patients, sometimes leaving almost no other treating option, but amputation surgery. In wound healing process, platelets play one of key roles, both in hemostasis, and, by releasing many growth factors, in reepithelization and tissue remodeling. Platelet concentrates are defined as autologous or homologous platelet derivatives with a platelet concentration higher than it is usually in human blood. Concentration of platelets needed to affect wound healing should be 1,000,000/μl. This is a report about patient with pemphigus vulgaris and Type 2 diabetes mellitus, who got injury of the left lower leg. Traditional surgical methods of wound closure and vacuum‐assisted closure therapy were ineffective. Homologous platelet gel was used topically, resulting in wound closure, without any adverse effects.